BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
May 24, 2010
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Cempra, Optimer preclinical data

In human monocytic cells in vitro, CEM-101 significantly inhibited matrix metalloproteinase 9 (MMP9), tumor necrosis factor...

Read the full 79 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >